Peter Schraml
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
Papers in
-
- Renal and related cancers 26
- Epigenetics and DNA Methylation 18
- Gene expression and cancer classification 9
-
- Cancer Genomics and Diagnostics 34
- Cancer, Hypoxia, and Metabolism 18
- Co-authors
- Holger Moch (101 shared papers)Guido Sauter (35 shared papers)Michael J. Mihatsch (25 shared papers)Juha Kononen (14 shared papers)Lukas Bubendorf (12 shared papers)J. Torhorst (4 shared papers)Maarit Bärlund (1 shared paper)Stephen B. Leighton (1 shared paper)
- Journals
- Oncogene (10 papers)American Journal Of Pathology (9 papers)The Journal of Pathology (7 papers)International Journal of Cancer (7 papers)Modern Pathology (7 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Peter Schraml
157 papers receiving 12.3k citations
Peter Schraml's Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 3.0k
- Oncology 3.6k
- Pulmonary and Respiratory Medicine 2.9k
- Molecular Biology 6.6k
- Immunology and Allergy 360
Countries citing papers authored by Peter Schraml
This map shows the geographic impact of Peter Schraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schraml more than expected).
Fields of papers citing papers by Peter Schraml
This network shows the impact of papers produced by Peter Schraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schraml. The network helps show where Peter Schraml may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tissue microarrays for high-throughput molecular profiling of tumor specimens Hit paper breakdown → | 1998 | 3350 |
| 2 | Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Hit paper breakdown → | 1999 | 504 |
| 3 | Tissue microarrays for gene amplification surveys in many different tumor types. | 1999 | 387 |
| 4 | 1999 | 327 | |
| 5 | 1999 | 302 | |
| 6 | 2004 | 292 | |
| 7 | Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. | 2000 | 280 |
| 8 | 2017 | 275 | |
| 9 | 2001 | 246 | |
| 10 | 2004 | 201 | |
| 11 | 1998 | 195 | |
| 12 | 2001 | 182 | |
| 13 | 2004 | 182 | |
| 14 | 2012 | 178 | |
| 15 | Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. | 2001 | 167 |
| 16 | 2003 | 153 | |
| 17 | 2016 | 153 | |
| 18 | 2013 | 137 | |
| 19 | 2009 | 133 | |
| 20 | 2013 | 131 |
About Peter Schraml
Peter Schraml is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 159 papers that have together received 12.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (34 papers), Renal cell carcinoma treatment (32 papers), Renal and related cancers (26 papers), Epigenetics and DNA Methylation (18 papers), Cancer, Hypoxia, and Metabolism (18 papers), HER2/EGFR in Cancer Research (11 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Gene expression and cancer classification (9 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (3.6k citations), Pulmonary and Respiratory Medicine (2.9k citations), Molecular Biology (6.6k citations) and Immunology and Allergy (360 citations). Peter Schraml has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Holger Moch, Guido Sauter, Michael J. Mihatsch, Juha Kononen, Lukas Bubendorf, J. Torhorst, Maarit Bärlund, Stephen B. Leighton, Olli Kallioniemi and Ronald Simon. Their work appears in journals such as Oncogene, American Journal Of Pathology, The Journal of Pathology, International Journal of Cancer and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.